MedPath
NMPA Approval

Trastuzumab Injection

S20160001

January 18, 2016

S20110059

Drug Information

注射用曲妥珠单抗

赫赛汀

注射剂

150mg/瓶,使用时以7.2ml无菌注射用水(未提供)配制

生物制品

January 18, 2016

January 17, 2021

Company Information

Applicant Company

Schoenmattstrasse 2, 4153 Reinach, Switzerland

Manufacturing Company

Grenzacherstrasse 124 4070 Basel, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用曲妥珠单抗 - NMPA 批准文号 | MedPath